Role of retinal pigment epithelial cell β-catenin signaling in experimental proliferative vitreoretinopathy

American Journal of Pathology

Volumn 184, Issue 5, 2014, Pages 1419-1428

  Umazume, Kazuhiko ^a   Tsukahara, Rintaro ^a   Liu, Lanhsin ^a   Fernandez De Castro, Juan P ^a   McDonald, Kevin ^a   Kaplan, Henry J ^a   Tamiya, Shigeo ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CARBENOXOLONE; COLLAGEN TYPE 1; CONNEXIN 43; FH 535; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; FH535; SULFONAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEDIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FEMALE; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DETACHMENT; RETINAL PIGMENT EPITHELIAL CELL; VITREORETINOPATHY; WNT SIGNALING PATHWAY; ANIMAL; CELL MOTION; DRUG EFFECTS; ELECTROPHYSIOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; MEMBRANE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION; SWINE;

ANIMALS; BETA CATENIN; CELL DEDIFFERENTIATION; CELL MOVEMENT; CONNEXIN 43; ELECTROPHYSIOLOGICAL PHENOMENA; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; MEMBRANES; RETINAL PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION; SULFONAMIDES; SUS SCROFA; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84899554299     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.01.022     Document Type: Article

References (59)

1. J. Rosenbloom, F.A. Mendoza, and S.A. Jimenez Strategies for anti-fibrotic therapies Biochim Biophys Acta 1832 2012 1088 1103
2. The classification of retinal detachment with proliferative vitreoretinopathy Ophthalmology 90 1983 121 125
3. J.A. Cardillo, J.T. Stout, L. LaBree, S.P. Azen, L. Omphroy, J.Z. Cui, H. Kimura, D.R. Hinton, and S.J. Ryan Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome Ophthalmology 104 1997 1166 1173
4. J.C. Pastor, E.R. de la Rúa, and F. Martín Proliferative vitreoretinopathy: risk factors and pathobiology Prog Retin Eye Res 21 2002 127 144
5. P. Hiscott, C. Sheridan, R.M. Magee, and I. Grierson Matrix and the retinal pigment epithelium in proliferative retinal disease Prog Retin Eye Res 18 1999 167 190
6. H. Nagasaki, K. Shinagawa, and M. Mochizuki Risk factors for proliferative vitreoretinopathy Prog Retin Eye Res 17 1998 77 98
7. S.Y. Oberstein, J. Byun, D. Herrera, E.A. Chapin, S.K. Fisher, and G.P. Lewis Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration Mol Vis 17 2011 1794 1805
8. D.G. Charteris, C.S. Sethi, G.P. Lewis, and S.K. Fisher Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology Eye 16 2002 369 374
9. A. Bringmann, and P. Wiedemann Involvement of Müller glial cells in epiretinal membrane formation Graefes Arch Clin Exp Ophthalmol 247 2009 865 883
10. R. Machemer Pathogenesis and classification of massive periretinal proliferation Br J Ophthalmol 62 1978 737 747
11. C. Guidry The role of Müller cells in fibrocontractive retinal disorders Prog Retin Eye Res 24 2005 75 86
12. S. Saika, O. Yamanaka, K.C. Flanders, Y. Okada, T. Miyamoto, T. Sumioka, K. Shirai, A. Kitano, K. Miyazaki, S. Tanaka, and K. Ikeda Epithelial- mesenchymal transition as a therapeutic target for prevention of ocular tissue fibrosis Endocr Metab Immune Disord Drug Targets 8 2008 69 76
13. I. Morino, P. Hiscott, N. McKechnie, and I. Grierson Variation in epiretinal membrane components with clinical duration of the proliferative tissue Br J Ophthalmol 74 1990 393 399
14. H. Yamashita, S. Hori, and K. Masuda Population and proportion of component cells in preretinal membranes Jpn J Ophthalmol 30 1986 269 281
15. P.A. Campochiaro Pathogenic mechanisms in proliferative vitreoretinopathy Arch Ophthalmol 115 1997 237 241
16. S. Tamiya, L. Liu, and H.J. Kaplan Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact Invest Ophthalmol Vis Sci 51 2010 2755 2763
17. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition [Erratum appeared in J Clin Invest 2010, 120:1786] J Clin Invest 119 2009 1420 1428
18. R.P. Casaroli-Marano, R. Pagan, and S. Vilaró Epithelial- mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells Invest Ophthalmol Vis Sci 40 1999 2062 2072
19. S. Grisanti, and C. Guidry Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype Invest Ophthalmol Vis Sci 36 1995 391 405
20. P.J. Morin beta-Catenin signaling and cancer Bioessays 21 1999 1021 1030
21. A.P. Lam, and C.J. Gottardi β-Catenin signaling: a novel mediator of fibrosis and potential therapeutic target Curr Opin Rheumatol 23 2011 562 567
22. S. Handeli, and J.A. Simon A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities Mol Cancer Ther 7 2008 521 529
23. M. Vaid, R. Prasad, Q. Sun, and S.K. Katiyar Silymarin targets beta-catenin signaling in blocking migration/invasion of human melanoma cells PloS One 6 2011 e23000
24. K. Umazume, L. Liu, P.A. Scott, J.P. Fernandez de Castro, K. McDonald, H.J. Kaplan, and S. Tamiya Inhibition of PVR with a tyrosine kinase inhibitor, dasatinib, in the swine Invest Ophthalmol Vis Sci 54 2013 1150 1159
25. M. van Noort, J. Meeldijk, R. van der Zee, O. Destree, and H. Clevers Wnt signaling controls the phosphorylation status of beta-catenin J Biol Chem 277 2002 17901 17905
26. C.C. Liang, A.Y. Park, and J.L. Guan In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro Nat Protoc 2 2007 329 333
27. S.K. Parapuram, B. Chang, L. Li, R.A. Hartung, K.V. Chalam, J.U. Nair-Menon, D.M. Hunt, and R.C. Hunt Differential effects of TGFbeta and vitreous on the transformation of retinal pigment epithelial cells Invest Ophthalmol Vis Sci 50 2009 5965 5974
28. F. Grinnell, and W.M. Petroll Cell motility and mechanics in three-dimensional collagen matrices Annu Rev Cell Dev Biol 26 2010 335 361
29. F. Grinnell, C.H. Ho, Y.C. Lin, and G. Skuta Differences in the regulation of fibroblast contraction of floating versus stressed collagen matrices J Biol Chem 274 1999 918 923
30. S.A. Morales, S. Mareninov, P. Prasad, M. Wadehra, J. Braun, and L.K. Gordon Collagen gel contraction by ARPE-19 cells is mediated by a FAK-Src dependent pathway Exp Eye Res 85 2007 790 798
31. D. Meitinger, D.M. Hunt, D.T. Shih, J.C. Fox, and R.C. Hunt Vitreous-induced modulation of integrins in retinal pigment epithelial cells: effects of fibroblast growth factor-2 Exp Eye Res 73 2001 681 692
32. M.H. el-Fouly, J.E. Trosko, and C.C. Chang Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication Exp Cell Res 168 1987 422 430
33. S. Sonoda, C. Spee, E. Barron, S.J. Ryan, R. Kannan, and D.R. Hinton A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells Nat Protoc 4 2009 662 673
34. K. Umazume, Y. Barak, K. McDonald, L. Liu, H.J. Kaplan, and S. Tamiya Proliferative vitreoretinopathy in the swine-a new model Invest Ophthalmol Vis Sci 53 2012 4910 4916
35. I. Sanchez, R. Martin, F. Ussa, and I. Fernandez-Bueno The parameters of the porcine eyeball Graefes Arch Clin Exp Ophthalmol 249 2011 475 482
36. R. Machemer, T.M. Aaberg, H.M. Freeman, A.R. Irvine, J.S. Lean, and R.M. Michels An updated classification of retinal detachment with proliferative vitreoretinopathy Am J Ophthalmol 112 1991 159 165
37. M.A. van der Heyden, M.B. Rook, M.M. Hermans, G. Rijksen, J. Boonstra, L.H. Defize, and O.H. Destrée Identification of connexin43 as a functional target for Wnt signalling J Cell Sci 111 1998 1741 1749
38. B.T. MacDonald, K. Tamai, and X. He Wnt/beta-catenin signaling: components, mechanisms, and diseases Dev Cell 17 2009 9 26
39. H.C. Chen, Y.T. Zhu, S.Y. Chen, and S.C. Tseng Wnt signaling induces epithelial-mesenchymal transition with proliferation in ARPE-19 cells upon loss of contact inhibition Lab Invest 92 2012 676 687
40. T. Valenta, G. Hausmann, and K. Basler The many faces and functions of β-catenin EMBO J 31 2012 2714 2736
41. H. Lei, M.A. Rhéaume, G. Velez, S. Mukai, and A. Kazlauskas Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells Invest Ophthalmol Vis Sci 52 2011 5016 5021
42. A. Parrales, E. López, and A.M. López-Colomé Thrombin activation of PI3K/PDK1/Akt signaling promotes cyclin D1 upregulation and RPE cell proliferation Biochim Biophys Acta 1813 2011 1758 1766
43. S. Pennock, M.A. Rhéaume, S. Mukai, and A. Kazlauskas A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy Am J Pathol 179 2011 2931 2940
44. C. Hecquet, G. Lefevre, M. Valtink, K. Engelmann, and F. Mascarelli Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation Invest Ophthalmol Vis Sci 43 2002 3091 3098
45. M. Oyamada, K. Takebe, and Y. Oyamada Regulation of connexin expression by transcription factors and epigenetic mechanisms Biochim Biophys Acta 1828 2013 118 133
46. S. Diederich, M. Quinkler, P. Burkhardt, C. Grossmann, V. Bahr, and W. Oelkers 11Beta-hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine Eur J Clin Invest 30 Suppl 3 2000 21 27
47. Y.S. Cho, C.H. Kim, and H.G. Cheon Cell-based assay for screening 11beta-hydroxysteroid dehydrogenase 1 inhibitors Anal Biochem 392 2009 110 116
48. E.P. Gomez-Sanchez, D. Cox, M. Foecking, V. Ganjam, and C.E. Gomez-Sanchez 11 beta-hydroxysteroid dehydrogenases of the choriocarcinoma cell line JEG-3 and their inhibition by glycyrrhetinic acid and other natural substances Steroids 61 1996 110 115
49. C. Leckie, K.E. Chapman, C.R. Edwards, and J.R. Seckl LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors Endocrinology 136 1995 5561 5569
50. F.A. Patel, K. Sun, and J.R. Challis Local modulation by 11beta-hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydroxyprostaglandin dehydrogenase in human chorion and placental trophoblast cells J Clin Endocrinol Metab 84 1999 395 400
51. J.C. Saez, V.M. Berthoud, M.C. Branes, A.D. Martinez, and E.C. Beyer Plasma membrane channels formed by connexins: their regulation and functions Physiol Rev 83 2003 1359 1400
52. J.L. Solan, and P.D. Lampe Connexin43 phosphorylation: structural changes and biological effects Biochem J 419 2009 261 272
53. B. Bao, J. Jiang, T. Yanase, Y. Nishi, and J.R. Morgan Connexon-mediated cell adhesion drives microtissue self-assembly FASEB J 25 2011 255 264
54. M.L. Cotrina, J.H. Lin, and M. Nedergaard Adhesive properties of connexin hemichannels Glia 56 2008 1791 1798
55. P. Kameritsch, K. Pogoda, and U. Pohl Channel-independent influence of connexin 43 on cell migration Biochim Biophys Acta 1818 2012 1993 2001
56. H.P. Ehrlich, and T. Diez Role for gap junctional intercellular communications in wound repair Wound Repair Regen 11 2003 481 489
57. H.P. Ehrlich, B. Sun, G.C. Saggers, and F. Kromath Gap junction communications influence upon fibroblast synthesis of type I collagen and fibronectin J Cell Biochem 98 2006 735 743
58. B. Liu, D.J. Hunter, S. Rooker, A. Chan, Y.M. Paulus, P. Leucht, Y. Nusse, H. Nomoto, and J.A. Helms Wnt signaling promotes Müller cell proliferation and survival after injury Invest Ophthalmol Vis Sci 54 2013 444 453
59. B.D. White, R.J. Nathe, D.O. Maris, N.K. Nguyen, J.M. Goodson, R.T. Moon, and P.J. Horner beta-Catenin signaling increases in proliferating NG2+ progenitors and astrocytes during post-traumatic gliogenesis in the adult brain Stem Cells 28 2010 297 307